StockViz
RANKINGS
Verastem, Inc.
NasdaqCM:VSTM
Sector
Industries
Location
Market Cap
USD 283.54 M
Share Price
USD 5.16
Avg Daily Volume
2,164,791
Change (1 day)
0.98%
Change (1 year)
56.84%
Change (YTD)
-0.19%
Verastem, Inc. Income Statement 2015 - 2025
This table shows the Income Statement for Verastem, Inc. going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Novartis AG
USD 115.07
NOVN.SW
-0.81
-0.70%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Vertex Pharmaceuticals Incorporated
USD 459.81
VRTX
-3.46
-0.75%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
CSL Limited
USD 167.39
CSL.AX
+6.23
3.87%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%